Plasmin is not protective in experimental renal interstitial fibrosis

Kidney International

Volumn 66, Issue 1, 2004, Pages 68-76

  Edgtton, Kristy L ^b   Gow, Renae M ^b   Kelly, Darren J ^b   Carmeliet, Peter ^b   Kitching, A Richard ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Collagen; Fibrinolysis; Fibrosis; Kidney failure; Macrophage; Plasmin

Indexed keywords

ALPHA ACTIN; COLLAGEN; GELATINASE A; GELATINASE B; HYDROXYPROLINE; MESSENGER RNA; PLASMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; KIDNEY FIBROSIS; MACROPHAGE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; URETER LIGATION; URETER OBSTRUCTION;

EID: 3042720541     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00707.x     Document Type: Article

References (40)

1. EDDY AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15:290-301, 2000
2. PLOPLIS VA, CARMELIET P, VAZIRZADEH S, et al: Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92:2585-2593, 1995
3. CARMELIET P, SCHOONJANS L, KIECKENS L, et al: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424, 1994
4. SAPPINO AP, HUARTE J, VASSALLI JD, BELIN D: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970, 1991
5. ANGLES-CANO E, RONDEAU E, DELARUE F, et al: Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54:688-692, 1985
6. KITCHING AR, HOLDSWORTH SR, PLOPLIS VA, et al: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185:963-968, 1997
7. ODA T, JUNG YO, KIM HS, et al: PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60:587-596, 2001
8. YANG J, SHULTZ RW, MARS WM, et al: Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110:1525-1538, 2002
9. ZHANG G, KIM H, CAI X, et al: Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 14:1254-1271, 2003
10. SWAISGOOD CM, FRENCH EL, NOGA C, et al: The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157:177-187, 2000
11. POHL JF, MELIN-ALDANA H, SABLA G, et al: Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury. Am J Pathol 159:2179-2186, 2001
12. PLOPLIS VA, FRENCH EL, CARMELIET P, et al: Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 91:2005-2009, 1998
13. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
14. BORDER WA, NOBLE NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
15. ISAKA Y, TSUJIE M, ANDO Y, et al: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892, 2000
16. MUNGER JS, HARPEL JG, GLEIZES PE, et al: Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
17. CARMELIET P, MOONS L, PLOPLIS V, et al: Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200-208, 1997
18. YU HC, BURRELL LM, BLACK MJ, et al: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621-2628, 1998
19. MA J, NISHIMURA H, FOGO A, et al: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53:937-944, 1998
20. BERGMAN I, LOXLEY R: Two improved and simplified methods for the spectrophotometric determination of hyroxproline. Anal Chem 35:1961-1965, 1963
21. TIPPING PG, HUANG XR, BERNDT MC, HOLDSWORTH SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 46:79-88, 1994
22. HUANG XR, HOLDSWORTH SR, TIPPING PG: Evidence for delayed type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
23. GILBERT RE, WILKINSON-BERKA JL, JOHNSON DW, et al: Renal expression of transforming growth factor-beta inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney Int 54:1052-1062, 1998
24. ZHANG J, NIE G, JIAN W, et al: Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation. Biol Reprod 59:693-703, 1998
25. ZHANG G, KIM H, CAI X, et al: Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. J Am Soc Nephrol 14:1234-1253, 2003
26. ROMER J, BUGGE TH, PYKE C, et al: Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med 2:287-292, 1996
27. NAGAI N, DE MM, LIJNEN HR, et al: Role of plasminogen system components in focal cerebral ischemic infarction: A gene targeting and gene transfer study in mice. Circulation 99:2440-2444, 1999
28. CARMELIET P, COLLEN D: Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 91:255-285, 1998
29. FALCONE DJ, BORTH W, KHAN KM, HAJJAR KA: Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97:777-784, 2001
30. LANGE-SPERANDIO B, CACHAT F, THORNHILL BA, CHEVALIER RL: Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 61:516-524, 2002
31. NISHIDA M, FUJINAKA H, MATSUSAKA T, et al: Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110:1859-1868, 2002
32. NAISH P, PENN GB, EVANS DJ, PETERS DK: The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 42:643-646, 1972
33. DREW AF, TUCKER HL, LIU H, et al: Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol 281:F1157-F1163, 2001
34. HOLDSWORTH SR, THOMSON NM, GLASGOW EF, ATKINS RC: The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: Studies using glomerular culture and electronmicroscopy. Clin Exp Immunol 37:38-43, 1979
35. MASAKI T, CHOW F, NIKOLIC-PATERSON DJ, et al: Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant 18:178-181, 2003
36. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
37. LIJNEN HR, VAN HOEF B, LUPU F, et al: Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscl Thromb Vasc Biol 18:1035-1045, 1998
38. YANG J, LIU Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475, 2001
39. TOFOVIC SP, DUBEY R, SALAH EM, JACKSON EK: 2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol 13:2737-2747, 2002
40. KOH SC, YUEN R, VIEGAS OA, et al: Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females. Thromb Haemost 66:581-585, 1991